ConductScience.org, home

Trial · NCT02706470

Use of Cyclosporin A for the Treatment of Recurrent Miscarriage

NCT02706470, Phase 2, Phase 3, Unknown, Fudan University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Use of Cyclosporin A for the Treatment of Recurrent Miscarriage. Trials, record NCT02706470. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02706470

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Use of Cyclosporin A for the Treatment of Recurrent Miscarriage
NCT number
NCT02706470
Status
Unknown
Phases
Phase 2, Phase 3
Enrollment
384 participants, estimated
Lead sponsor
Fudan University
Conditions
Miscarriage, Recurrent
Interventions
Cyclosporin A, Dydrogesterone
First posted
2016-03-11
Last updated
2016-03-15

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryLive birth rateUp to 36 monthsThe difference in the live birth rates between patients with recurrent miscarriage assigned oral CsA and Dydrogesterone.
SecondaryThe difference in the rate of miscarriage between patients with recurrent miscarriage treated with CsA and Dydrogesterone.Up to 36 monthsThe difference in the rates of miscarriage (pregnancy loss before 20 weeks gestation) between patients assigned oral CsA and Dydrogesterone.
SecondaryFetal deathUp to 36 monthsThe difference in the rates of fetal death (fetal death after 20 weeks of gestational age) between patients assigned oral CsA and Dydrogesterone.
SecondaryThe difference in the rate of premature delivery between patients treated with CsA and Dydrogesterone.Up to 36 monthsThe difference in the rates of premature delivery (deliveries with gestational age less than 37 weeks) between patients assigned oral CsA and Dydrogesterone.
SecondaryCongenital malformationsUp to 36 monthsThe difference in the rates of congenital malformations between patients assigned oral CsA and Dydrogesterone.
SecondaryMaternal outcomes: morbidity of infectious diseaseUp to 36 monthsThe difference of morbidity of infectious disease in pregnancy between two arms.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers12

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
17229932BACKGROUNDPubMed
17566014BACKGROUNDPubMed
17636278BACKGROUNDPubMed
18299432BACKGROUNDPubMed
18322274BACKGROUNDPubMed
22495096BACKGROUNDPubMed
22766276BACKGROUNDPubMed
22848341BACKGROUNDPubMed
23028901BACKGROUNDPubMed
23410723BACKGROUNDPubMed

1 to 10 of 12

See all 12 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02706470

GET https://conductscience.org/api/trials/v1/NCT02706470/registered